Chinese Journal of Pharmacovigilance ›› 2011, Vol. 8 ›› Issue (10): 587-589.
Previous Articles Next Articles
ZHANG Xiao-ying1, PENG Yan-li2, CHEN Tao1, ZHU Ya-li1, WEI Jin-ming1, WANG Yan1, JIA Juan1
Received:
2011-07-18
Online:
2011-10-10
Published:
2015-07-30
CLC Number:
ZHANG Xiao-ying, PENG Yan-li, CHEN Tao, ZHU Ya-li, WEI Jin-ming, WANG Yan, JIA Juan. The Evaluation of Diagnoses and Management in Cesarean Scar Pregnancy with Color Doppler Ultrasound[J]. Chinese Journal of Pharmacovigilance, 2011, 8(10): 587-589.
[1] Larsen J V, Solomom M H. Pregnancy in a uterine scar sacculus: an unusual cause of posabortal hemorrhage[J]. South Afr Med J,1978,53:142-143. [2] Seow K M, Hwang J L,Tsai Y L,et al. Subsequent pregnancy outcome after conservative treatment of a previous cesarean scar pregnancy[J].Acta Obstet Gynecol Scand, 2004,83:1167-1172. [3] Godin P A, Bassil S, Donnez J. An ectopic pregnancy developing in a previous caesarean section scar[J].Fertil Steril, 1997,67:398-400. [4] McKenna D A, Poder L, Goldman M.Role of sonography in the recognition, assessment, and treatment of cesarean scar ectopic pregnancies[J].J Ultrasound Med,2008,27(5):779-783. [5] Rotas M A, Haberman S, Levgur M, et al. Cesarean scar ectopic pregnancies: etiology, diagnosis, and management[J].Obstet Gynecol,2006,107(6):1373-81. |
[1] | SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126. |
[2] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[3] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[4] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[5] | JIA Yinyin, ZHANG Caishu, ZHOU Ying, LIU Li, GENG Ying, WEI Ningyi, NIU Sijing, CHEN Hua, XU Hui. Evaluation methods for aerodynamic particle size distribution of fine particles in inhaled products [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 141-146. |
[6] | GUO Ningzi, LIU Li, YUE Ruiqi, FENG Huiqing, YANG Huaxin, WEI Ningyi, CHEN Hua. Determination of particle size distribution of chiglitazar sodium by laser diffraction method [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 147-151. |
[7] | NING Xiao, GAO Guanghui, JIN Shaoming, LIU Tongtong, PEI Yusheng, CAO Jin. Determination of erythromycin ointment content based on on-line column switching and liquid chromatography [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 152-155. |
[8] | ZHANG Zan, ZHANG Hui, HE Songhua, LUO Yi. Four exogenously-polluted components in Tianwang Buxin pills analyzed via TLC and UPLC-QQQ-MS [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 156-162. |
[9] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[10] | MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin. Drug traceability coding system in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172. |
[11] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[12] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[13] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[14] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[15] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||